Opioid Use Disorder Statistics in Wisconsin

Opioid Use Disorder (OUD) represents a significant public health challenge in Wisconsin, mirroring a broader national crisis but with distinct local characteristics. The state faces elevated prevalence rates compared to national averages, alongside persistent difficulties in ensuring adequate access to treatment, particularly in rural areas. Understanding the scope of this issue through data is the first step toward developing effective, targeted interventions. These statistics shed light on the populations most at risk, the severity of outcomes like overdose, and the ongoing efforts to expand care and save lives across the state.

Measuring the prevalence of Opioid Use Disorder is essential for allocating resources and understanding the scale of the public health response needed. In Wisconsin, the rate of OUD is a key indicator of the crisis's depth. The state's prevalence is situated within a broader context of mental health challenges, where approximately 20% of adults experienced any mental illness in 2022^[3], and 5% suffered from a serious mental illness^[4]. When compared to other states, recent analyses have placed Wisconsin near the midpoint—approximately 25th among U.S. states—for OUD prevalence^[2]. The following data provides a direct comparison of OUD rates in Wisconsin against national figures for both adults and youth.

Access to timely and effective treatment is a cornerstone of combating the opioid crisis, yet many Wisconsinites face significant barriers. Data reveals a concerning gap, with some reports indicating that nearly 70% of individuals with a diagnosed OUD do not receive any form of treatment^[2], and another suggesting only 37% accessed services in 2023^[2]. This low utilization points to systemic issues including provider shortages, stigma, and logistical challenges^[2]. However, policy changes are making an impact; the expansion of Medicaid coverage has been associated with a 10% increase in treatment enrollment^[1], and about 70% of low-income individuals with OUD enrolled in Medicaid now benefit from expanded services^[5].

The burden of Opioid Use Disorder is not distributed evenly across Wisconsin's population. Certain demographic groups face a disproportionately higher risk due to a combination of factors including economic distress, persistent stigma, and limited access to care^[7]. Young adults, particularly those aged 20-25, are a high-risk group due to economic stressors and reduced treatment engagement^[8]. Furthermore, a significant urban-rural divide exists, which may be attributable to socioeconomic factors and the limited availability of specialized treatment centers in rural areas^[1]. Examining these disparities is crucial for creating equitable public health strategies.

Demographic data also reveals trends related to race and gender. While males are slightly more affected by OUD, trends over the past five years have shown a gradual increase in the proportion of female cases^[1]. Similarly, recent data show that minority communities are experiencing notable increases in OUD prevalence, suggesting that economic disparities and uneven access to health services may be exacerbating the disorder's impact in these groups^[9]. The table below shows the distribution of reported OUD cases among different populations in the state.

The most severe outcome of the opioid crisis is the rising number of fatal overdoses. In 2023, Wisconsin's opioid overdose death rate was 25.1 deaths per 100,000 residents, a figure approximately 4.6% higher than the national average^[1]. Opioids are a factor in over 80% of all overdose deaths in the state^[1]. This high mortality rate suggests that many individuals may not be receiving timely or appropriate treatment^[1]. While the overall trend in fatalities is concerning, there are some positive signs; suspected opioid overdose ambulance runs decreased by 15% in 2023 compared to the previous year^[2].

Beyond overdose, OUD is linked to numerous other serious health consequences. Injection drug use is a primary vector for blood-borne illnesses, and the crisis has led to increased rates of infectious diseases. Additionally, in-utero opioid exposure has led to a rise in neonatal opioid withdrawal syndrome, affecting the most vulnerable from the moment of birth. In 2020, 16.3 out of every 1,000 births in Wisconsin were diagnosed with the condition^[1]. These associated conditions add another layer of complexity and cost to the public health crisis.